Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
Boehringer Ingelheim has awarded WPP’s Mindshare U.S. media duties for its prescription pharmaceuticals business, according to sources.
The client markets brands such as Flomax and Spiriva. The switch will take effect next year.
Boehringer spent about $225 million in measured media for its prescription drugs in 2008, and $155 million for the first 10 months of 2009, per Nielsen.
The incumbent on the business is Havas’ MPG. Sources said the shift is being made without a review.
Last month, the client awarded Mindshare non-U.S.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in